Category Archives: Uncategorized


Ambassador Mark Dybul, O’Neill Institute Co-Director of the Global Health Law Program and Distinguished Scholar, Appointed Executive Director of the Global Fund for AIDS, Tuberculosis and Malaria

November 15, 2012 – The O’Neill Institute for National and Global Health Law at Georgetown University congratulates Ambassador Mark Dybul, O’Neill Institute Co-Director of the Global Health Law Program and Distinguished Scholar, on his appointment as the next Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria.  He will join the Fund […]

Read More

Posted in Uncategorized; Tagged: , , , .


Could a Romney Administration Really Dismantle the ACA “On Day One”?

This post was written by Madhu Chugh. Ms. Chugh is a scholar at the O’Neill Institute at Georgetown University Law Center and an attorney at Wilmer Cutler Pickering Hale and Dorr LLP.  The views expressed in this post are the author’s alone and do not reflect the views of WilmerHale or the O’Neill Institute. Mitt […]

Read More

Posted in Health reform, National Healthcare, Uncategorized; Tagged: , , , , .


Professor Lawrence Gostin in JAMA Forum “How Realistic Is Romney’s Pledge to “Repeal and Replace” the Affordable Care Act?”

This post was written by Lawrence O. Gostin, Faculty Director of the O’Neill Institute.  and was originally published in the JAMA Forum on October 18, 2012. The “Repeal and Replace” Strategy Romney’s preferred strategy to repeal and replace the ACA would undoubtedly rely on a parliamentary tactic called the budget reconciliation process, the very method […]

Read More

Posted in Uncategorized; Tagged: , , , .


Coca-Cola Helps the Global Fund Deliver Medicines: A Look at the Ethics of Public-Private Partnerships

In the Institute’s last blog posting, Tanya Baytor commented on how large manufacturers of unhealthy foods, including Coca-Cola, McDonald’s and Cadbury’s, took advantage of the Olympics to associate their products with health.  Tanya raised the concern that these companies’ exclusive Olympic sponsorship deals helped them market to children, a segment of the population which is […]

Read More

Posted in Global Health, Uncategorized;


PrEP News: FDA Approves First Drug for HIV Prevention

The Food and Drug Administration announced today its approval of tenofovir-emtricitabine (aka Truvada) for HIV prevention.  Truvada, which has been approved since 2004 for use in HIV treatment, is now approved for use as preexposure prophylaxis (“PrEP”)–a strategy in which an HIV-negative person uses an antiretroviral drug (in this case a daily pill) to reduce […]

Read More

Posted in Uncategorized;


Archives

Stay Informed

Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute

Or sign up for our RSS Feed

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.